|

anti-CLL-1 CAR NK cells Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1

Indications

  • Relapsed Adult AML1
  • Refractory AML1
  • Cancer1

Other1 trial

CLL-1 CAR-NK Cells for Relapsed/Refractory AML
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.